BACKGROUND AND PURPOSE: Brain hypervascular diseases are complex and induce hemodynamic disturbances on brain parenchyma, which are difficult to accurately evaluate by using perfusion-weighted (PWI) MR imaging. Our purpose was to test and to assess the best AIF estimation method among 4 patients with brain hypervascular disease and healthy volunteers. METHODS: Thirty-three patients and 10 healthy volunteers underwent brain perfusion studies by using a 1.5T MR imaging scanner with gadolinium-chelate bolus injection. PWI was performed with the indicator dilution method. AIF estimation methods were performed with local, regional, regional scaled, and global estimated arterial input function (AIF), and PWI measurements (cerebral blood volume [CBV] and cerebral blood flow [CBF]) were performed with regions of interest drawn on the thalami and centrum semiovale in all subjects, remote from the brain hypervascular disease nidus. Abnormal PWI results were assessed by using Z Score, and evaluation of the best AIF estimation method was performed by using a no gold standard evaluation method. RESULTS: From 88% to 97% of patients had overall abnormal perfusion areas of hypo- (decreased CBV and CBF) and/or hyperperfusion (increased CBV and CBF) and/or venous congestion (increased CBV, normal or decreased CBF), depending on the AIF estimation method used for PWI computations. No gold standard evaluation of the 4 AIF estimates found the regional and the regional scaled methods to be the most accurate. CONCLUSION: Brain hypervascular disease induces remote brain perfusion abnormalities that can be better detected by using PWI with regional or regional scaled AIF estimation methods.
BACKGROUND AND PURPOSE:Brain hypervascular diseases are complex and induce hemodynamic disturbances on brain parenchyma, which are difficult to accurately evaluate by using perfusion-weighted (PWI) MR imaging. Our purpose was to test and to assess the best AIF estimation method among 4 patients with brain hypervascular disease and healthy volunteers. METHODS: Thirty-three patients and 10 healthy volunteers underwent brain perfusion studies by using a 1.5T MR imaging scanner with gadolinium-chelate bolus injection. PWI was performed with the indicator dilution method. AIF estimation methods were performed with local, regional, regional scaled, and global estimated arterial input function (AIF), and PWI measurements (cerebral blood volume [CBV] and cerebral blood flow [CBF]) were performed with regions of interest drawn on the thalami and centrum semiovale in all subjects, remote from the brain hypervascular disease nidus. Abnormal PWI results were assessed by using Z Score, and evaluation of the best AIF estimation method was performed by using a no gold standard evaluation method. RESULTS: From 88% to 97% of patients had overall abnormal perfusion areas of hypo- (decreased CBV and CBF) and/or hyperperfusion (increased CBV and CBF) and/or venous congestion (increased CBV, normal or decreased CBF), depending on the AIF estimation method used for PWI computations. No gold standard evaluation of the 4 AIF estimates found the regional and the regional scaled methods to be the most accurate. CONCLUSION:Brain hypervascular disease induces remote brain perfusion abnormalities that can be better detected by using PWI with regional or regional scaled AIF estimation methods.
Authors: R Wirestam; L Andersson; L Ostergaard; M Bolling; J P Aunola; A Lindgren; B Geijer; S Holtås; F Ståhlberg Journal: Magn Reson Med Date: 2000-05 Impact factor: 4.668
Authors: John J Lee; G Larry Bretthorst; Colin P Derdeyn; William J Powers; Tom O Videen; Abraham Z Snyder; Joanne Markham; Joshua S Shimony Journal: Magn Reson Med Date: 2010-05 Impact factor: 4.668
Authors: Andreas Stadlbauer; Stefan Oberndorfer; Max Zimmermann; Bertold Renner; Michael Buchfelder; Gertraud Heinz; Arnd Doerfler; Andrea Kleindienst; Karl Roessler Journal: J Cereb Blood Flow Metab Date: 2019-02-07 Impact factor: 6.200
Authors: Andreas Stadlbauer; Karl Roessler; Max Zimmermann; Michael Buchfelder; Andrea Kleindienst; Arnd Doerfler; Gertraud Heinz; Stefan Oberndorfer Journal: Mol Imaging Biol Date: 2019-08 Impact factor: 3.488
Authors: Andreas Stadlbauer; Max Zimmermann; Arnd Doerfler; Stefan Oberndorfer; Michael Buchfelder; Roland Coras; Melitta Kitzwögerer; Karl Roessler Journal: Neuro Oncol Date: 2018-10-09 Impact factor: 12.300